JP2019509264A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509264A5 JP2019509264A5 JP2018541195A JP2018541195A JP2019509264A5 JP 2019509264 A5 JP2019509264 A5 JP 2019509264A5 JP 2018541195 A JP2018541195 A JP 2018541195A JP 2018541195 A JP2018541195 A JP 2018541195A JP 2019509264 A5 JP2019509264 A5 JP 2019509264A5
- Authority
- JP
- Japan
- Prior art keywords
- adjuvant
- vaccine
- virus
- administered
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023000567A JP2023036949A (ja) | 2016-02-04 | 2023-01-05 | ワクチンアジュバントとしての間葉系幹細胞及びそれを使用するための方法 |
| JP2025173389A JP2026012755A (ja) | 2016-02-04 | 2025-10-15 | ワクチンアジュバントとしての間葉系幹細胞及びそれを使用するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291350P | 2016-02-04 | 2016-02-04 | |
| US62/291,350 | 2016-02-04 | ||
| PCT/US2017/016200 WO2017136539A1 (en) | 2016-02-04 | 2017-02-02 | Mesenchymal stem cells as vaccine adjuvants and methods for using the same |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023000567A Division JP2023036949A (ja) | 2016-02-04 | 2023-01-05 | ワクチンアジュバントとしての間葉系幹細胞及びそれを使用するための方法 |
| JP2025173389A Division JP2026012755A (ja) | 2016-02-04 | 2025-10-15 | ワクチンアジュバントとしての間葉系幹細胞及びそれを使用するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019509264A JP2019509264A (ja) | 2019-04-04 |
| JP2019509264A5 true JP2019509264A5 (https=) | 2020-03-12 |
| JP7814090B2 JP7814090B2 (ja) | 2026-02-16 |
Family
ID=58261704
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541195A Active JP7814090B2 (ja) | 2016-02-04 | 2017-02-02 | ワクチンアジュバントとしての間葉系幹細胞及びそれを使用するための方法 |
| JP2023000567A Pending JP2023036949A (ja) | 2016-02-04 | 2023-01-05 | ワクチンアジュバントとしての間葉系幹細胞及びそれを使用するための方法 |
| JP2025173389A Pending JP2026012755A (ja) | 2016-02-04 | 2025-10-15 | ワクチンアジュバントとしての間葉系幹細胞及びそれを使用するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023000567A Pending JP2023036949A (ja) | 2016-02-04 | 2023-01-05 | ワクチンアジュバントとしての間葉系幹細胞及びそれを使用するための方法 |
| JP2025173389A Pending JP2026012755A (ja) | 2016-02-04 | 2025-10-15 | ワクチンアジュバントとしての間葉系幹細胞及びそれを使用するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11975068B2 (https=) |
| EP (2) | EP4316497A3 (https=) |
| JP (3) | JP7814090B2 (https=) |
| KR (1) | KR20180105705A (https=) |
| AU (2) | AU2017213812B2 (https=) |
| CA (1) | CA3013457A1 (https=) |
| ES (1) | ES2960206T3 (https=) |
| IL (1) | IL260858B (https=) |
| SG (1) | SG11201806587RA (https=) |
| WO (1) | WO2017136539A1 (https=) |
| ZA (2) | ZA201805159B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020166063A1 (ja) * | 2019-02-15 | 2020-08-20 | 大和薬品株式会社 | フレイル改善方法およびフレイル改善食品 |
| CN111568927A (zh) * | 2020-05-23 | 2020-08-25 | 湖南源品细胞生物科技有限公司 | 一种msc用于调节记忆b细胞数量的应用 |
| JP2023540096A (ja) | 2020-09-08 | 2023-09-21 | ロングエバーオン インコーポレイテッド | アロジェニック間葉系幹細胞によるアルツハイマー病の治療 |
| CN112641938A (zh) * | 2020-11-22 | 2021-04-13 | 翁炳焕 | 一种dna重组干细胞载体新冠疫苗 |
| US20220218817A1 (en) * | 2021-01-08 | 2022-07-14 | Vitro Biopharma, Inc. | Immune modulation by mesenchymal stem cells |
| CN117999082A (zh) | 2021-07-26 | 2024-05-07 | 美商生命科学有限公司 | 间充质干细胞在治疗青少年左心发育不良综合征中的用途 |
| WO2025137077A1 (en) | 2023-12-19 | 2025-06-26 | Longeveron, Inc. | Improved brain architecture and biomarkers in alzheimer's disease with mesenchymal stem cells |
| WO2025199451A2 (en) | 2024-03-21 | 2025-09-25 | Longeveron Inc. | Mmp-14 potency assay for mesenchymal stem cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2999199A (en) | 1998-04-03 | 1999-10-25 | Osiris Therapeutics, Inc. | Mesenchymal stem cells as immunosuppressants |
| US8554280B2 (en) | 2010-03-23 | 2013-10-08 | Ebay Inc. | Free-form entries during payment processes |
| US10472647B2 (en) | 2012-12-21 | 2019-11-12 | The Administrators Of The Tulane Educational Fund | Primary mesenchymal stem cells as a vaccine platform |
| WO2014100857A1 (en) | 2012-12-24 | 2014-07-03 | Cell Ideas Pty Ltd | Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy |
| US9101597B2 (en) | 2013-03-14 | 2015-08-11 | The Administration Of The Tulane Educational Fund | Immunoprotective primary mesenchymal stem cells and methods |
| CN104138391B (zh) | 2013-05-08 | 2018-07-31 | 中国科学院上海生命科学研究院 | 间充质干细胞在预防或治疗应激反应导致的免疫力下降中的应用 |
-
2017
- 2017-02-02 WO PCT/US2017/016200 patent/WO2017136539A1/en not_active Ceased
- 2017-02-02 EP EP23199388.2A patent/EP4316497A3/en active Pending
- 2017-02-02 KR KR1020187025027A patent/KR20180105705A/ko not_active Withdrawn
- 2017-02-02 AU AU2017213812A patent/AU2017213812B2/en active Active
- 2017-02-02 SG SG11201806587RA patent/SG11201806587RA/en unknown
- 2017-02-02 ES ES17709498T patent/ES2960206T3/es active Active
- 2017-02-02 CA CA3013457A patent/CA3013457A1/en active Pending
- 2017-02-02 JP JP2018541195A patent/JP7814090B2/ja active Active
- 2017-02-02 US US16/075,276 patent/US11975068B2/en active Active
- 2017-02-02 EP EP17709498.4A patent/EP3411050B1/en active Active
-
2018
- 2018-07-30 IL IL260858A patent/IL260858B/en unknown
- 2018-07-31 ZA ZA2018/05159A patent/ZA201805159B/en unknown
-
2020
- 2020-01-29 ZA ZA2020/00574A patent/ZA202000574B/en unknown
-
2023
- 2023-01-05 JP JP2023000567A patent/JP2023036949A/ja active Pending
-
2024
- 2024-04-08 US US18/629,427 patent/US20240252627A1/en active Pending
- 2024-07-03 AU AU2024204598A patent/AU2024204598A1/en active Pending
-
2025
- 2025-10-15 JP JP2025173389A patent/JP2026012755A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019509264A5 (https=) | ||
| Lichty et al. | Vesicular stomatitis virus: re-inventing the bullet | |
| Geisbert et al. | Prospects for immunisation against Marburg and Ebola viruses | |
| US10821143B2 (en) | Chimeric VSV virus compositions and methods of use thereof for treatment of cancer | |
| Hasanpourghadi et al. | COVID-19 vaccines based on adenovirus vectors | |
| Echaide | Chocarro de Erauso | |
| MX363409B (es) | Antigenos y vacunas dirigidos contra enterovirus hunanos. | |
| EA201390812A1 (ru) | Лиофилизированные вирусные составы | |
| KR102104650B1 (ko) | 급속 및 지속적 면역학적제제-치료제 | |
| EA201390810A1 (ru) | Жидкие вирусные составы | |
| ES2689150T3 (es) | Métodos para la prevención de agregación de componentes víricos | |
| Grant-Klein et al. | Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses | |
| JP2009501901A5 (https=) | ||
| ES3056141T3 (en) | Simian adenoviral vectors with two expression cassettes | |
| CU20120057A7 (es) | Composición vacunal contra el virus del dengue, kit y plásmido | |
| RU2014140731A (ru) | Варианты гемагглютинина и нейраминидазы гриппа | |
| ES2540526T3 (es) | Virus del sarampión oncolítico | |
| RU2018103757A (ru) | Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита | |
| Kim et al. | Generation of VHSV replicon particles carrying transmembrane and C-terminal cytoplasmic region-deleted G gene (rVHSV-GΔTM) and comparison of vaccine efficacy with G gene-deleted VHSV (rVHSV-ΔG) | |
| AU2018275790B2 (en) | Genetically attenuated nucleic acid vaccine | |
| DOP2014000215A (es) | Virus de la enfermedad de marek modificado y vacunas elaboradas con él | |
| JP2016514114A5 (https=) | ||
| RU2017110225A (ru) | Способ получения вакцинных антигенов, получаемые вакцинные антигены и их применение | |
| Kumari et al. | COVID-19 Vaccines: A possible solution to ongoing pandemic | |
| JP2003520573A5 (https=) |